Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
1	1 Humacyte HUMA $292M	505% upside 4 price targets	0
2	2 Compass Therapeutics CMPX $408M	499% upside 3 price targets	0
3	3 Iovance Biotherapeutics IOVA $887M	390% upside 3 price targets	0
4	4 Kura Oncology KURA $573M	347% upside 4 price targets	0
5	5 Astria Therapeutics ATXS $381M	339% upside 3 price targets	0
6	CMPS 6 Compass Pathways CMPS $407M	330% upside 4 price targets	0
7	7 Olema Pharmaceuticals OLMA $360M	328% upside 4 price targets	0
8	8 Gossamer Bio GOSS $446M	308% upside 3 price targets	0
9	9 Structure Therapeutics GPCR $1.07B	307% upside 4 price targets	0
10	ALMS 10 Alumis Inc. Common Stock ALMS $453M	301% upside 5 price targets	0
11	11 Regenxbio RGNX $458M	290% upside 3 price targets	0
12	CAN 12 Canaan Creative CAN $358M	237% upside 4 price targets	0
13	13 ATAI Life Sciences ATAI $851M	233% upside 3 price targets	0
14	14 Sagimet Biosciences SGMT $279M	223% upside 4 price targets	0
15	15 CytomX Therapeutics CTMX $290M	222% upside 3 price targets	0
16	16 Intellia Therapeutics NTLA $1.17B	221% upside 7 price targets	0
17	TECX 17 Tectonic Therapeutic, Inc. Common Stock TECX $458M	218% upside 4 price targets	0
18	18 Lexeo Therapeutics LXEO $259M	213% upside 3 price targets	0
19	19 Biohaven BHVN $1.45B	212% upside 7 price targets	0
20	BCYC 20 Bicycle Therapeutics BCYC $511M	212% upside 4 price targets	0
21	21 Trevi Therapeutics TRVI $912M	210% upside 5 price targets	0
22	22 Taysha Gene Therapies TSHA $769M	206% upside 6 price targets	0
23	23 Vera Therapeutics VERA $1.36B	202% upside 3 price targets	0
24	24 Prothena Corp PRTA $434M	201% upside 7 price targets	0
25	25 Perspective Therapeutics CATX $289M	201% upside 4 price targets	0

12345

12